PMID: 21642448

Caldwell RA, Grove DE, Houck SA, Cyr DM
Increased folding and channel activity of a rare cystic fibrosis mutant with CFTR modulators.
Am J Physiol Lung Cell Mol Physiol. 2011 Sep;301(3):L346-52. Epub 2011 Jun 3., [PubMed]
Sentences
No. Mutations Sentence Comment
35 ABCC7 p.Val232Asp
X
ABCC7 p.Val232Asp 21642448:35:33
status: NEW
view ABCC7 p.Val232Asp details
The folding defect caused by the V232D mutation appears to be due to the introduction of a charged residue into a region of CFTR that is embedded in the lipid bilayer of the ER membrane (17, 24). Login to comment
36 ABCC7 p.Val232Asp
X
ABCC7 p.Val232Asp 21642448:36:47
status: NEW
view ABCC7 p.Val232Asp details
Since the folding defect in CFTR caused by the V232D mutation is correctable to wild-type levels, CF patients with this allele may benefit from treatment with folding correctors. Login to comment
37 ABCC7 p.Val232Asp
X
ABCC7 p.Val232Asp 21642448:37:33
status: NEW
view ABCC7 p.Val232Asp details
The folding defect caused by the V232D mutation appears to be due to the introduction of a charged residue into a region of CFTR that is embedded in the lipid bilayer of the endoplasmic reticulum (ER) membrane (17, 24). Login to comment
38 ABCC7 p.Val232Asp
X
ABCC7 p.Val232Asp 21642448:38:47
status: NEW
view ABCC7 p.Val232Asp details
Since the folding defect in CFTR caused by the V232D mutation is correctable to wild-type levels, CF patients with this allele may benefit from treatment with folding correctors. Login to comment
154 ABCC7 p.Val232Asp
X
ABCC7 p.Val232Asp 21642448:154:32
status: NEW
view ABCC7 p.Val232Asp details
Yet, the mechanism by which the V232D mutation causes CF is not well documented and whether patients with this mutation can be treated with modulators of CFTR folding and channel activity is not clear. Login to comment
156 ABCC7 p.Val232Asp
X
ABCC7 p.Val232Asp 21642448:156:4
status: NEW
view ABCC7 p.Val232Asp details
The V232D mutation is proposed to cause aberrant hydrogen bonding between TM4 and adjacent TM segments in CFTR (24). Login to comment
165 ABCC7 p.Val232Asp
X
ABCC7 p.Val232Asp 21642448:165:63
status: NEW
view ABCC7 p.Val232Asp details
Thus, CF patients that harbor low frequency mutations, such as V232D, might be treated with small molecules that correct CFTR misfolding or potentiate CFTR channel activity. Login to comment
169 ABCC7 p.Val232Asp
X
ABCC7 p.Val232Asp 21642448:169:37
status: NEW
view ABCC7 p.Val232Asp details
In doing so, Corr-4a may prevent the V232D mutation from causing the aberrant hydrogen bonding between TM segments in the bilayer proposed to cause premature degradation of CFTRV232D (24). Login to comment
191 ABCC7 p.Val232Asp
X
ABCC7 p.Val232Asp 21642448:191:31
status: NEW
view ABCC7 p.Val232Asp details
Yet the mechanism by which the V232D mutation causes CF is not well documented, and whether patients with this mutation can be treated with modulators of CFTR folding and channel activity is not clear. Login to comment
193 ABCC7 p.Val232Asp
X
ABCC7 p.Val232Asp 21642448:193:4
status: NEW
view ABCC7 p.Val232Asp details
The V232D mutation is proposed to cause aberrant hydrogen bonding between TM4 and adjacent TM segments in CFTR (24). Login to comment
202 ABCC7 p.Val232Asp
X
ABCC7 p.Val232Asp 21642448:202:62
status: NEW
view ABCC7 p.Val232Asp details
Thus CF patients that harbor low-frequency mutations, such as V232D, might be treated with small molecules that correct CFTR misfolding or potentiate CFTR channel activity. Login to comment
206 ABCC7 p.Val232Asp
X
ABCC7 p.Val232Asp 21642448:206:37
status: NEW
view ABCC7 p.Val232Asp details
In doing so, Corr-4a may prevent the V232D mutation from causing the aberrant hydrogen bonding between TM segments in the bilayer proposed to cause premature degradation of CFTRV232D (24). Login to comment